中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
19期
25-26
,共2页
李朋辉%钟玲%李佳%陈斌辉
李朋輝%鐘玲%李佳%陳斌輝
리붕휘%종령%리가%진빈휘
终末期肝病模型%自发性腹膜炎%肝硬化
終末期肝病模型%自髮性腹膜炎%肝硬化
종말기간병모형%자발성복막염%간경화
Model for end-stage liver disease%Spontaneous bacterial peritonitis%Cirrhosis
目的:探讨终末期肝病模型(MELD)对于肝硬化腹水合并自发性腹膜炎(SBP)的临床预测价值。方法收集肝硬化腹水患者127例,根据是否合并SBP分为SBP组(33例)和非SBP组(94例),比较两组的MELD评分;并根据MELD评分分为A组(≤9分)、B组(10~19分)、C组(20~29组)和D组(≥30分),比较5组SBP发生率。结果 SBP组的MELD得分显著高于非SBP组(P<0.05);MELD得分与SBP发生率呈显著正相关性(P<0.05)。结论 MELD评分对于肝硬化腹水发生SBP具有重要的临床预测价值,MELD得分与SBP发生率呈正相关性。
目的:探討終末期肝病模型(MELD)對于肝硬化腹水閤併自髮性腹膜炎(SBP)的臨床預測價值。方法收集肝硬化腹水患者127例,根據是否閤併SBP分為SBP組(33例)和非SBP組(94例),比較兩組的MELD評分;併根據MELD評分分為A組(≤9分)、B組(10~19分)、C組(20~29組)和D組(≥30分),比較5組SBP髮生率。結果 SBP組的MELD得分顯著高于非SBP組(P<0.05);MELD得分與SBP髮生率呈顯著正相關性(P<0.05)。結論 MELD評分對于肝硬化腹水髮生SBP具有重要的臨床預測價值,MELD得分與SBP髮生率呈正相關性。
목적:탐토종말기간병모형(MELD)대우간경화복수합병자발성복막염(SBP)적림상예측개치。방법수집간경화복수환자127례,근거시부합병SBP분위SBP조(33례)화비SBP조(94례),비교량조적MELD평분;병근거MELD평분분위A조(≤9분)、B조(10~19분)、C조(20~29조)화D조(≥30분),비교5조SBP발생솔。결과 SBP조적MELD득분현저고우비SBP조(P<0.05);MELD득분여SBP발생솔정현저정상관성(P<0.05)。결론 MELD평분대우간경화복수발생SBP구유중요적림상예측개치,MELD득분여SBP발생솔정정상관성。
Objective To investigate the clinical predictive value of model for end-stage liver disease (MELD) for liver cirrhosis complicated with spontaneous bacterial peritonitis (SBP). Methods 127 cases of patients with liver cirrhosis were divided into SBP group(33 cases) and non-SBP group (94 cases) according to whether the patients complicated by SBP. The MELD scores of the two groups were compared; and the patients were divided into group A (≤9 points), group B (10-19 points), group C (20-29 points) and group D (≥30 points) in accordance with the MELD score, and the incidences of SBP of five groups were compared. Results The MELD score of SBP group was significantly higher than that of non-SBP group (P<0.05); MELD score and the incidence of SBP was significantly positively correlated (P<0.05). Conclusion MELD score has important clinical predictive value for liver cir-rhosis complicated by SBP, and it is positively correlated with the incidence of SBP.